NCT06181786View on ClinicalTrials.gov

Study of NAV-240 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions
Healthy
Interventions
DRUG

NAV-240

Intravenous administration of NAV-240

DRUG

Placebo

Intravenous administration of matching placebo for NAV-240

Trial Locations (1)

33136

Syneos Health, Miami

Sponsors

Collaborators (1)

IMBiologics Corp.
All Listed Sponsors
collaborator

IMBiologics Corp.

INDUSTRY

lead

Navigator Medicines, Inc.

INDUSTRY